[Comment] 2020 cancer incidence data in the USA reveal effects of the COVID-19 pandemic

Routine screening for breast, cervical, and colorectal cancers decreased substantially after the COVID-19 public health emergency was declared in early 2020.1,2 This decrease was largely due to facility closures, local policies to limit viral spread, and cancelation of non-emergency procedures.1,2 Screening generally rebounded later in 2020, but not uniformly across all areas of the USA or segments of the population.1,2 Some people might have also delayed seeking medical care during the height of the pandemic for symptoms suggestive of cancer because of concerns regarding contact with SARS-CoV-2.